Introduction

CD8
+ T-cells are essential for effective immunity against HIV-1 and the induction of such responses using vaccines has become a major objective in the strategy to halt the pandemic 1 .
However, the recent outcome of the Merck STEP study, the most ambitious trial of an anti-HIV T-cell-based vaccine conducted to date, has been a major disappointment 2 . Despite its immunogenicity, the vaccine failed both to prevent infection of vaccinated volunteers at high risk of acquiring HIV and to reduce viral load set points in infected vaccinees. This failure has roused the scientific community to step back and reconsider its basic knowledge of Tcell-mediated efficacy 3, 4 . Indeed, consensual opinion is that our general understanding of Tcell efficacy in HIV-1 infection is actually still limited, which represents a clear obstacle to the design of successful vaccines.
Over recent years, qualitative attributes of CD8 + T-cells have increasingly become the focus of attempts to identify reliable correlates of immune protection against HIV. Among these, polyfunctionality 5 and HIV suppressive activity 6 have been associated with spontaneous control of HIV infection and slower disease progression rates in infected patients. Of note, polyfunctionality is currently seen as the best correlate of T-cell efficacy measurable directly ex vivo 7 . Polyfunctional CD8 + T-cells are those that exhibit multiple effector functions (i.e.
degranulation and production of anti-viral factors) simultaneously upon antigen encounter;
this can be assessed after stimulation with cognate peptides by multiparametric flow cytometry (e.g. mobilization of CD107 and intracellular production of IFN-γ, TNF-α, IL-2, and MIP-1β) 5 . HIV suppressive activity reflects the capacity of HIV specific CD8+ T-cells to eliminate HIV infected targets via classical class I MHC restricted cytotoxic lysis 6, 8 . It can be assessed using primary CD4 + T-cells infected in vitro with HIV in the presence of HIVspecific CD8 + T-cells. However, although consistent qualitative properties generally identify
For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From HIV-specific CD8 + T-cell populations that are associated with lower HIV replication rates, the issue of cause and effect remains difficult to determine in ex vivo studies. Furthermore, the factors that link these functional outcomes are not well defined.
We recently reported that, in addition to polyfunctional profiles, HIV-specific CD8 + T-cells that are associated with superior control of HIV-1 replication display high levels of antigen sensitivity 9 . Based on these observations and a review of the literature, we proposed that antigen sensitivity may be an important facet of T-cell efficacy in HIV infection 10 . However, contrasting data have been reported. For instance, it was recently suggested that HIV-specific CD8 + T-cells with polyfunctional profiles are actually those that display low, rather than high, levels of antigen sensitivity 11 . Moreover, CD8 + T-cell polyfunctionality has been shown to depend inversely on HIV load 12, 13 ; such observations suggest that polyfunctionality is a consequence of low antigen levels rather than the cause of improved viral containment.
Virus-specific CD8 + T-cells differ with respect to many parameters, including: (i) intrinsic factors, such as HLA restriction, target antigen and T-cell receptor (TCR); (ii) ontogenetic factors, such as replicative history, differentiation status and activation profile. Each of these parameters is known to affect T-cell properties directly and influence the control of HIV-1
replication. This heterogeneity in the nature and environment of individual CD8 + T-cells is a substantial obstacle to the deconvolution of functional complexity in relation to the control of HIV-1 replication; it may also explain the contrasting findings in the literature and hence the current confusion as regards the determinants of CD8 + T-cell efficacy. To overcome this issue and investigate the relationship between different functional attributes associated with T-cell efficacy in HIV-1 infection, we established a controlled system using HIV-specific CD8 + Tcell clones isolated in vitro; importantly, all of these clones were specific for the same HIVderived epitope (p24 Gag KK10; residues 263-272) and restricted by the same HLA class I 1 μg/ml) and human (h)rIL-2 (150 IU/ml). HIV-specific CD4 + T-cell clones were generated by in vitro priming using HIV infected autologous monocytes derived dendritic cells and subsequently expanded as previously described 17 . Clones demonstrated specificity for an epitope in HIV-1 p24 Gag (residues 271-290). HLA matched EBV-transformed B cell lines used to present antigen in cytolytic and polyfunctional assays were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), antibiotics and L-glutamine. Peptide specific clones were screened using IFNγ ELISA and tetramer staining.
Monoclonal antibodies, amine reactive dyes and peptide/HLA class I tetramers
Tetrameric antigen complexes for KK10/HLA-B*2705 and NV9/HLA-A*0201 NL9 were generated as described previously 18, 19 . Directly conjugated monoclonal antibodies (mAbs)
were obtained from the following vendors: (i) αCD3-Cy5.5PerCP, αCD8-APC, αCD4-APCCy7, αCD107a-Cy5PE, αCD40L-PE, αIL-2-APC, αIFNγ-Alexa700 and αTNFα-PECy7 (iv) αCD4-ECD, αCD8-Cy5PE, and αKC57/p24-FITC (Beckman Coulter, Miami, FL). The amine reactive viability dye ViViD (Molecular Probes, Eugene, OR) was used to eliminate dead cells from the analysis as described previously 20 . Staining with all reagents was conducted according to standard procedures 21, 22 .
Clonotype analysis
Clonality of expanded clones was confirmed by molecular analysis of TCR gene expression, conducted using a template-switch anchored RT-PCR as described previously 23, 24 . Twenty TCRB sequences tested were generated for each clone; clonality was validated when a single productive TCRB sequence was repeatedly obtained for a given clone. The IMGT nomenclature system is used throughout 19, 23 . Spots were counted using an automated ELISpot reader (Zeiss, Le Pecq, France).
Measure of antigen sensitivity
Polyfunctional analysis
For polyfunctional profiling, PBMC or T-cell clones together with antigen presenting cells as appropriate were incubated in the presence of specific peptide at the indicated concentrations and pre-titered αCD107a mAb for 1 hour at 37°C/5% CO 2 , followed by an further 5 hours in the presence of monensin (2.5 µg/ml; Sigma-Aldrich, St. Louis, MO) and brefeldin A (5µg/ml; Sigma-Aldrich); negative controls were processed in parallel for all experiments in the absence of peptide. The BD Cytofix/Cytoperm™ kit was used to permeabilize cells according to the manufacturer's instructions prior to staining for intracellular markers.
Analysis was performed using DIVA and FlowJo v8.2 (TreeStar Inc., San Carlos, CA) software after acquisition of stained cells on a standard LSRII flow cytometer (BD).
Multifunctional data were analyzed with PESTLE v1.3.2 and SPICE v3.1 (Mario Roederer, ImmunoTechnology Section, VRC/NIAID/NIH).
Assessment of HIV suppressive activity
Primary HLA B*2705 + CD4 + T-cells were purified (>99%) from freshly isolated PBMC by positive selection with antibody-coated magnetic beads ( Miltenyi Biotec, Paris, France). 
Statistics
Group medians and distributions were compared using the Mann-Whitney U-test or the Wilcoxon signed rank test. Associations between variables were determined by the nonparametric Spearman rank correlation test. P values below 0.05 were considered significant.
Results
Generation of CD8+ T-cell clones with different antigen sensitivities
In order to assess the impact of antigen sensitivity on the attributes of CD8 + T-cell efficacy,
we generated a bank of HIV-specific CD8 + T-cell clones specific for the immunodominant HLA B*2705-restricted p24 Gag KK10 epitope (residues 263-272); this restriction element and targeted antigenic protein are both associated with improved control of HIV-1 replication 25, 26 . These HIV-specific CD8 + T-cell clones were isolated from the peripheral blood of three HIV-infected donors using KK10/HLA B*2705 tetramers combined with flow cytometric sorting and then expanded in vitro according to standard protocols; clonality was confirmed by TCR sequencing ( 
Link between antigen sensitivity and CD8 + T-cell polyfunctionality
The polyfunctional profile of representative clones that displayed different levels of antigen sensitivity was then assessed by multiparamteric flow cytometry ( Fig. 2A) . For stimulation, target cells were incubated with 10 -8 M peptide concentration, thought to be close to the amount of peptide that real infection generates on cell surface 27 . Importantly, these assays were performed on equivalently "resting" clones two weeks post-restimulation to circumvent any potential bias related to activation status. Among the clones selected for these assays (n=10), we included clones with identical TCRB sequence for internal control (see framed dots in figure 2C ). A caveat is though that we only performed TCRB sequencing, and it is possible that clones with the same TCRB chain might have different TCRV chain and therefore not be identical clonotypes. the antigen sensitivity of all these clones was superior for the wild type KK10 peptide, compared to a L 268 M variant KK10 peptide, which corresponds to an escape mutation commonly observed in HIV infected patients (data not shown). Notably, while all clones elicited at least one function upon antigen encounter, highly sensitive clones displayed more polyfunctional profiles compared to clones with lower levels of antigen sensitivity (representative examples are shown in figure 2B ). Indeed, there was a direct link between CD8 + T-cell antigen sensitivity and polyfunctionality, as shown by a significant positive correlation between these two parameters (Fig. 2C) . Likewise, in the presence of primary CD4+ T cells infected with HIV ( Fig. 2D ) (i.e. endogenous presentation of the antigen), CD8 + T-cell clones with higher antigen sensitivity showed a stronger polyfunctional profile (Fig. 2E ).
Functional outcomes upon antigen engagement depend on the strength of the stimulus 28 , which can be directly affected by the level of antigen sensitivity. In a related manner, several studies have also shown that the functional profile of T-cells can be dictated by antigen concentration [29] [30] [31] [32] . To address these issues in our study, we determined the polyfunctional profiles of representative KK10-specific CD8 + T-cell clones in peptide titration assays.
Progressive increases in antigen concentration stimulated more polyfunctional outcomes (Fig.   2F ). Although apparently paucifunctional during initial screening (Fig. 2B ), CD8 + T-cell clones with lower levels of antigen sensitivity displayed enhanced polyfunctional profiles at
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From supra-optimal peptide concentrations. Nonetheless, at any given antigen density, greater proportions of the population were polyfunctional in highly sensitive CD8 + T-cell clones compared to their lower sensitivity counterparts. Similar observations were obtained using CD8 + T-cell clones specific for the HLA A*0201-restricted cytomegalovirus (CMV) pp65 NV9 epitope (residues 495-503) with distinct antigen sensitivity (data not shown), extending the relationship between polyfunctionality and antigen sensitivity to another specificity. The relevance of these observations was confirmed in assays conducted directly ex vivo. We assessed the functional profile of CD8 + T-cell populations specific for two distinct HIV antigens in peptide titration assays. Figure 3 shows CD8 + T-cell populations (from distinct donors) specific for the HLA B*2705-restricted KK10 epitope (Fig. 3A) or the HLA A*0301-restricted HIV-1 p24 Gag epitope RY10 (residues 20-29) (Fig. 3B ) that exhibited distinct antigen sensitivities. Ex vivo observation mirrored those obtained with the CD8 + T-cell clones; thus, regardless of specificity or experimental conditions, polyfunctionality was determined by antigen sensitivity and peptide concentration.
Sequential induction of functions with signal intensity
In order to get mechanistic insights into the relationship between polyfunctionality and antigen sensitivity, we analyzed the induction of individual functions independently (Fig.   4A ). In addition to being more polyfunctional, highly sensitivity clones also produced more IFNγ and/or TNFα and mobilized more CD107a on a per-cell basis compared to clones with lower levels of antigen sensitivity; this quantification of individual functions was assessed by MFI measurements gated solely on responsive cells stimulated at the highest peptide concentration (Fig. 4B) . Thus, the amount of produced cytokines is directly associated with the degree of activation at the single cell level. These observations are consistent with recent reports that showed an association between the magnitude of individual functions at the single cell level and the degree of polyfunctionality in polyclonal antigen-specific T-cell (Fig. 4D) . This sequential induction of functions with increasing TCR signal intensity provides an explanation for the relationship between antigen sensitivity and functional attributes. In sum, these data demonstrate the existence of a functional hierarchy in HIV-specific CD8 + T-cell clones that is determined by their antigen sensitivity.
Hierarchical functionality in CD4+ T-cells
To extend the applicability of these findings, we investigated also the functional (Fig. 5A ). The functional hierarchy was different from that observed for CD8 + T-cells; however, there was clear sequential induction of individual functions (Fig. 5B) . Furthermore, CD4 + T-cell polyfunctionality increased with the stimulus gradient and was more pronounced for the (Fig. 5C) . Thus, antigen sensitivity dictates T-cell functional response profiles regardless of specificity and lineage.
Potent suppression of HIV replication by highly sensitive CD8 + T-cells
Recently, it has been shown that the in vivo control of HIV-1 replication is associated with the capacity of CD8 + T-cells to suppress p24 production in primary CD4 + T-cell cultures infected with HIV-1, by eliminating target cells via perforin/granzyme B mediated cytolytic pathways 6, 8 . The measurement of HIV suppression has emerged as one of the most relevant approaches for assessing CD8 + T-cell efficacy against HIV 4 . We therefore tested the capacity of our KK10-specific CD8 + T-cell clones to suppress HIV replication under these conditions, using infected HLA B*2705 + primary CD4 + T-cells. Notably, the presence of highly sensitive CD8 + T-cell clones prevented the production of p24 in the infected CD4 + T-cell cultures to levels approaching those of the negative controls, i.e. in the complete absence of virus; thus, these CD8 + T-cells had almost totally suppressed HIV replication in this assay (Fig. 6A ).
However, KK10-specific clones with lower levels of antigen sensitivity were not as effective.
In fact, the presence of clones with the lowest antigen sensitivity had virtually no effect on the dynamics of HIV infection and replication (Fig. 6A) . Importantly, we found an inverse correlation between the proportion of infected cells expressing intracellular p24 and the antigen sensitivity of the CD8 + T-cell clones present in the cultures under equivalent conditions (Fig. 6B ).
To further explore the mechanistic basis of HIV suppressive activity, we tested in these assays the influences of the effector to target ratio as well as viral input. In the presence of disproportionate numbers of T-cell clones with lower levels of antigen sensitivity, apparent levels of HIV suppression could nonetheless be observed (Fig. 6C) . Finally, at lower multiplicities of infection, suppression of HIV replication could be achieved at lower effector
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From to target ratios (Fig. 6D) . This shows that, although the frequency of effector cells and the level of virus challenge are important parameters and can influence the efficiency of HIV suppression, under all conditions, highly sensitive clones exhibit greater potency in their ability to suppress HIV infection and replication, likely through more rapid recognition and elimination of target cells, as shown in mouse models 35 . Overall, this provides an explanation for our findings of an inverse correlation between the antigen sensitivity of immunodominant HIV specific CD8 + T cell populations measured ex vivo and the cell associated viral load in patients 9 . Of note, HIV infected patients harboring immunodominant HIV specific CD8 + T cell responses with higher antigen sensitivity presented clear trends towards lower plasma viral loads and higher CD4 counts (Fig. 6E ). resulting in effective target cell clearance 36, 37 ; this corresponds to the superior capacity of these cells to suppress HIV replication (Fig. 6) . Thus, overall, the qualitative attributes associated with T-cell efficacy are interlinked and governed by antigen sensitivity.
Previous studies which used isolated HIV specific CD8 + T-cell clones to assess their functional attributes reached diverging conclusions as to the importance of antigen sensitivity 38, 39 . These contrasting results may be related to the heterogeneity (in terms of target epitope and HLA restriction) 38 or the number (n=2) 39 of clones employed in these studies, which may hinder definite insights into the relevance of a specific parameter for CD8 + T-cell efficacy. This reinforces our strategy to generate a large number of clones, with an unique specificity, in order to perform adequate comparative analysis and explore the mechanistic Antigen sensitivity is known to depend on multiple factors. These include of course the affinity of the expressed TCR for antigen, but also additional factors not directly related to this primary interaction, such as molecular density and topography on the T-cell surface, coreceptor-mediated effects, membrane flexibility and differential triggering thresholds [40] [41] [42] .
Recent work suggests that the sensitivity of T cells to signals from the TCR may also be controlled at the level of miRNA expression. For instance, it was shown that during thymopoiesis, miR-181 changes the outcome of signaling triggered by TCR engagement by . This may be due to activationinduced regulatory pathways, such as the expression of inhibitory receptors like PD-1 48 , TCR-CD8 dissociation 49 or factors related to TCR downregulation 50, 51 , and may explain why T-cells from HIV-infected patients with high viral loads appear less functional in ex vivo assays 12,13,52 .
Although complex, this "non-hierarchical" combination of in vivo factors needs to be integrated into our comprehension of CD8 + T-cell-mediated control of HIV infection; the present work in this light simply highlights the importance of efforts that aim to dissect the respective contributions of these parameters to T-cell efficacy. We are currently engaged in biophysical and structural analyses of specific TCR peptide-MHC class I complex interactions, as well as genomics analysis (macroRNA and microRNA) of higher versus lower antigen sensitivity T-cells, in order to deconvolute the major determinants of antigen sensitivity with regards to CD8+ T cell efficacy. The induction of T-cells with high levels of antigen sensitivity could emerge as a major focus of vaccine design and more knowledge is needed with respect to the basis of antigen sensitivity. We recently reviewed possible approaches that may contribute to this goal, emphasizing the importance of antigen levels for T-cell priming and boosting, as well as the potentially crucial role of co-stimulatory pathways 10 . In this context, a recent study has shown that the use of TLR ligands as adjuvants in vaccination formulations can result in increasing TCR selection thresholds, thereby leading to the preferential expansion of clonotypes with high levels of antigen sensitivity 53 .
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